
Dan Harki
@danharki
Professor at the University of Minnesota. Medicinal Chemistry - Synthesis - Drug Discovery - Nucleic Acids - Chemical Biology.
ID: 763102597603397632
http://harki.umn.edu 09-08-2016 20:00:12
793 Tweet
1,1K Followers
379 Following



🚨 APOBEC3B (A3B) is a major source of🧬mutation in cancer The active site is like Teflon (not much binds) BUT Ozlem Dmr discovered a druggable allosteric site 👀 Experiments by Dan Harki Katherine Jones The Harris Lab 💪 biorxiv.org/content/10.110…


Our chemical synthesis of PTM-modified MYC peptides and their interactions with the tumor suppressor Bin1 is online Chemical Science. Congratulations @elysetwilliams, @rebeccabev5, Oliver Zerbe, and everyone else involved! 🎉 pubs.rsc.org/en/content/art… #MyFirstChemSci


At this spring's Cheers to U! Gratitude Celebration for donors, attendees heard from P4 student Ayan Mohamed; University of Minnesota Medicinal Chemistry grad student Caitlin Lichtenfels; & Dan Harki about how philanthropy has helped their respective journeys. View more photos ▶️ bit.ly/3wr5w83


Group lunch in honor of Emma Smith's last day in the #HarkiLab. Emma will be starting graduate studies Yale Chemistry in the fall. Good luck Emma!



Excited to see you all at the American Chemical Society National meeting in Denver! We have some fantastic programming for you and we hope you will join us for our social activities too! #Networking on Sunday (5-7pm), and the #HallofFame reception Tuesday evening!


The MEDI Executive Committee is here at the American Chemical Society meeting. We have some fantastic programming coming for this meeting and look forward to meeting with you all, and listening to some great science!




Excited to announce the start of EFMC-YMSC! A special thanks to Prof. Roberto Di Santo for his incredible effort in organising this incredible event, bringing together young scientists from across Europe. Thanks to the entire committee for making this possible! #EFMCYMSC



Join us for the @ClinicPharmSTL Research Seminar feat. Dan Harki from University of Minnesota Medicinal Chemistry. 📆 Oct. 10 @ 1p 🔬Chemical Strategies for Regulating DNA-Interactive Proteins: Targeting APOBEC Cytosine Deaminases & the N-Myc Transcription Factor 📍UHSP - ARB - Rm 449 anesthesiology.wustl.edu/events/event/c…



New publication from the #HarkiLab: A selective Aurora kinase A degrader that elicits N-Myc degradation in pediatric neuroblastoma. Thanks to everyone involved in this project! University of Minnesota Medicinal Chemistry UMN Department of Chemistry Masonic Cancer Center, University of Minnesota sciencedirect.com/science/articl…

Online now! Targeting N-Myc in neuroblastoma with selective Aurora kinase A degraders by Jian Tang, Dan Harki, and colleagues at University of Minnesota Medicinal Chemistry University of Minnesota UT Health San Antonio HHMI UC San Diego dlvr.it/THDH9Y #chembiol

Targeting N-Myc in neuroblastoma with selective Aurora kinase A degraders by Jian Tang, Dan Harki, and colleagues at University of Minnesota Medicinal Chemistry University of Minnesota UT Health San Antonio HHMI UC San Diego dlvr.it/TJ6WS4


Thanks C&EN (Chemical & Engineering News) for the highlight! cen.acs.org/acs-news/acs-m… via C&EN (Chemical & Engineering News)
